In focus
Latest feed
ELVN Shares Poised for Best Weekly Gain Since March Amid FDA Development Pathway News
Unpacking Northwest Biotherapeutics' Q1: A Biotech's Journey of Investment and Hope
A Glimpse Into Tomorrow's Cures: Anixa Biosciences Prepares for a Revealing Fireside Chat
The RNA Gamble: Avidity Biosciences Faces Its Next Big Test
